Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission

N Engl J Med. 2018 Feb 22;378(8):695-697. doi: 10.1056/NEJMp1714054. Epub 2018 Jan 10.

Authors

Steven Joffe¹, Holly Fernandez Lynch¹

Affiliation

¹ From the Department of Medical Ethics and Health Policy, Perelman School of Medicine, and the Leonard Davis Institute of Health Economics, University of Pennsylvania (S.J., H.F.L.), and the Children's Hospital of Philadelphia (S.J.) - all in Philadelphia.

PMID: 29320302
DOI: 10.1056/NEJMp1714054

No abstract available

MeSH terms

Clinical Trials, Phase I as Topic
Critical Illness
Drug Approval / legislation & jurisprudence*
Drug Evaluation / legislation & jurisprudence
Drug Industry / legislation & jurisprudence
Drug-Related Side Effects and Adverse Reactions
Drugs, Investigational*
Government Regulation*
Health Services Accessibility / legislation & jurisprudence*
Humans
Legislation, Drug*
Liability, Legal
Patient Safety / legislation & jurisprudence*
United States
United States Food and Drug Administration / legislation & jurisprudence*

Substances

Drugs, Investigational